ArticleCancer medicine2021

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.

Yusuke Funakoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.